{"id":"https://openalex.org/W2161864293","doi":"https://doi.org/10.1158/0008-5472.can-09-1355","title":"Adjuvant Hormonal Therapy for Breast Cancer and Risk of Hormone Receptor\u2013Specific Subtypes of Contralateral Breast Cancer","display_name":"Adjuvant Hormonal Therapy for Breast Cancer and Risk of Hormone Receptor\u2013Specific Subtypes of Contralateral Breast Cancer","publication_year":2009,"publication_date":"2009-08-26","ids":{"openalex":"https://openalex.org/W2161864293","doi":"https://doi.org/10.1158/0008-5472.can-09-1355","mag":"2161864293","pmid":"https://pubmed.ncbi.nlm.nih.gov/19706753","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2745902"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-09-1355","doi":"https://doi.org/10.1158/0008-5472.can-09-1355","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-09-1355","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/69/17/6865/2613320/6865.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/cancerres/article-pdf/69/17/6865/2613320/6865.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039757472","display_name":"Christopher I. Li","orcid":"https://orcid.org/0000-0003-1543-0743","observed_orcids":["https://orcid.org/0000-0003-1543-0743"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher I. Li","raw_affiliation_strings":["1Division of Public Health Sciences and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Public Health Sciences and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111802584","display_name":"Janet R. Daling","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janet R. Daling","raw_affiliation_strings":["1Division of Public Health Sciences and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Public Health Sciences and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091846363","display_name":"Peggy L. Porter","orcid":"https://orcid.org/0000-0002-8271-401X","observed_orcids":["https://orcid.org/0000-0002-8271-401X"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peggy L. Porter","raw_affiliation_strings":["1Division of Public Health Sciences and","2Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Public Health Sciences and","institution_ids":[]},{"raw_affiliation_string":"2Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101786907","display_name":"Mei-Tzu Chen Tang","orcid":"https://orcid.org/0000-0001-8185-6609","observed_orcids":["https://orcid.org/0000-0001-8185-6609"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mei-Tzu C. Tang","raw_affiliation_strings":["1Division of Public Health Sciences and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Public Health Sciences and","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074840024","display_name":"Kathleen E. Malone","orcid":"https://orcid.org/0000-0002-5643-6714","observed_orcids":["https://orcid.org/0000-0002-5643-6714"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathleen E. Malone","raw_affiliation_strings":["1Division of Public Health Sciences and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Public Health Sciences and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.3847,"has_fulltext":true,"cited_by_count":44,"citation_normalized_percentile":{"value":0.92593418,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"69","issue":"17","first_page":"6865","last_page":"6870"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14078","display_name":"Multiple and Secondary Primary Cancers","score":0.8838000297546387,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T14078","display_name":"Multiple and Secondary Primary Cancers","score":0.8838000297546387,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.10260000079870224,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adjuvant-endocrine-therapy","display_name":"adjuvant endocrine therapy","score":0.9580000042915344},{"id":"https://openalex.org/keywords/contralateral-breast-cancer","display_name":"contralateral breast cancer","score":0.9800000190734863},{"id":"https://openalex.org/keywords/second-primary-breast-cancer","display_name":"second primary breast cancer","score":0.8659999966621399},{"id":"https://openalex.org/keywords/hormone-receptor-negative-breast-cancer","display_name":"hormone receptor-negative breast cancer","score":0.8650000095367432},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.8999999761581421},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.9490000009536743},{"id":"https://openalex.org/keywords/breast-cancer-survivors","display_name":"breast cancer survivors","score":0.5619999766349792},{"id":"https://openalex.org/keywords/treatment-related-cancer-risk","display_name":"treatment-related cancer risk","score":0.48100000619888306}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.779805600643158},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7293919324874878},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.7140572667121887},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6853373050689697},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6661403179168701},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.6640155911445618},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5885783433914185},{"id":"https://openalex.org/C23589133","wikidata":"https://www.wikidata.org/wiki/Q412005","display_name":"Hormone receptor","level":4,"score":0.5667164921760559},{"id":"https://openalex.org/C2778311097","wikidata":"https://www.wikidata.org/wiki/Q5903784","display_name":"Hormonal therapy","level":4,"score":0.5633544921875},{"id":"https://openalex.org/C42407357","wikidata":"https://www.wikidata.org/wiki/Q521","display_name":"Physiology","level":1,"score":0.3218050003051758}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011960","descriptor_name":"Receptors, Estrogen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016609","descriptor_name":"Neoplasms, Second Primary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020845","descriptor_name":"Selective Estrogen Receptor Modulators","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020845","descriptor_name":"Selective Estrogen Receptor Modulators","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1158/0008-5472.can-09-1355","doi":"https://doi.org/10.1158/0008-5472.can-09-1355","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-09-1355","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/69/17/6865/2613320/6865.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:19706753","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19706753","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Comparative Study"},{"id":"pmh:oai:europepmc.org:2008690","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2745902","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:2745902","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2745902","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer Res","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.527.2621","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.527.2621","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://depts.washington.edu/epidem/News/0008-5472.CAN-09-1355v1.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.can-09-1355","doi":"https://doi.org/10.1158/0008-5472.can-09-1355","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-09-1355","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/69/17/6865/2613320/6865.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G2683189482","display_name":"Risk Factors for Second Primary Breast Cancer Among DCIS Survivors","funder_award_id":"R01CA097271","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2161864293.pdf","grobid_xml":"https://content.openalex.org/works/W2161864293.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1562190372","https://openalex.org/W1673285127","https://openalex.org/W1821522531","https://openalex.org/W1881540319","https://openalex.org/W2050870515","https://openalex.org/W2056696144","https://openalex.org/W2062795632","https://openalex.org/W2096366696","https://openalex.org/W2141798191","https://openalex.org/W2147764723","https://openalex.org/W2159752027","https://openalex.org/W2164353984","https://openalex.org/W2401039667"],"related_works":["https://openalex.org/W2408513248","https://openalex.org/W2141798191","https://openalex.org/W2105442326","https://openalex.org/W4416220954","https://openalex.org/W2091001821","https://openalex.org/W4403255287","https://openalex.org/W7099206034","https://openalex.org/W7096525123","https://openalex.org/W2913650362","https://openalex.org/W2914244619"],"abstract_inverted_index":{"Compared":[0,145],"with":[1,60,83,146,150,198,243],"the":[2,8,213,237],"breast":[3,12,26,68,74,86,96,133,167,188,201,220],"cancer":[4,13,69,75,97,134,168,202,221],"risk":[5,19,43,98,126,163,184,211],"women":[6,58,80,147],"in":[7],"general":[9],"population":[10],"have,":[11],"survivors":[14],"have":[15],"a":[16,22,51,84,161,178],"substantially":[17],"higher":[18],"of":[20,44,127,131,154,164,185,212,217,233,240],"developing":[21],"second":[23,71],"primary":[24,63,72],"contralateral":[25,47,73,132,166,187,200,219],"cancer.":[27,87,189],"Adjuvant":[28],"hormonal":[29,91,123,151,206],"therapy":[30,124,207],"reduces":[31],"this":[32],"risk,":[33],"but":[34,177],"preliminary":[35],"data":[36],"indicate":[37],"that":[38],"it":[39],"may":[40,222],"also":[41],"increase":[42],"hormone":[45,128],"receptor-negative":[46],"tumors.":[48,245],"We":[49],"conducted":[50,117],"population-based":[52],"nested":[53],"case-control":[54],"study":[55],"including":[56],"367":[57],"diagnosed":[59,81],"both":[61],"first":[62,85],"estrogen":[64],"receptor":[65],"(ER)-positive":[66],"invasive":[67],"and":[70,76,95,105,125,139],"728":[77],"matched":[78],"control":[79],"only":[82],"Data":[88],"on":[89],"adjuvant":[90,122,155,205],"therapy,":[92,152],"other":[93],"treatments,":[94],"factors":[99],"were":[100,116],"ascertained":[101],"through":[102],"telephone":[103],"interviews":[104],"medical":[106],"record":[107],"abstractions.":[108],"Two-sided":[109],"statistical":[110],"tests":[111],"using":[112],"conditional":[113],"logistic":[114],"regression":[115],"to":[118,225],"quantify":[119],"associations":[120],"between":[121],"receptor-specific":[129],"subtypes":[130],"(n":[135],"=":[136,141],"303":[137],"ER+":[138,165,244],"n":[140],"52":[142],"ER-":[143,186,199,218,241],"cases).":[144],"not":[148,196],"treated":[149],"users":[153],"tamoxifen":[156],"for":[157,192],">or=5":[158],"years":[159,194],"had":[160],"reduced":[162],"[odds":[169],"ratio,":[170],"0.4;":[171],"95%":[172],"confidence":[173],"interval":[174],"(CI),":[175],"0.3-0.7],":[176],"4.4-fold":[179],"(95%":[180],"CI,":[181],"1.03-19.0)":[182],"increased":[183],"Tamoxifen":[190],"use":[191],"<5":[193],"was":[195],"associated":[197],"risk.":[203],"Although":[204],"has":[208],"clear":[209],"benefits,":[210],"relatively":[214],"uncommon":[215],"outcome":[216],"now":[223],"need":[224],"be":[226],"tallied":[227],"among":[228],"its":[229],"risks.":[230],"This":[231],"is":[232],"clinical":[234],"concern":[235],"given":[236],"poorer":[238],"prognosis":[239],"compared":[242]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}